-
1
-
-
0034306969
-
Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
-
11034066
-
Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. S Huang JB Robinson A Deguzman CD Bucana IJ Fidler, Cancer Res 2000 60 5334 5339 11034066
-
(2000)
Cancer Res
, vol.60
, pp. 5334-5339
-
-
Huang, S.1
Robinson, J.B.2
Deguzman, A.3
Bucana, C.D.4
Fidler, I.J.5
-
2
-
-
85044705382
-
Assessment of prognostic factors in common ovarian tumors of varying malignancy
-
15520877
-
[Assessment of prognostic factors in common ovarian tumors of varying malignancy]. A Demeter T Varkonyi Z Csapo A Szantho J Olah Z Papp, Magy Onkol 2004 48 259 265 15520877
-
(2004)
Magy Onkol
, vol.48
, pp. 259-265
-
-
Demeter, A.1
Varkonyi, T.2
Csapo, Z.3
Szantho, A.4
Olah, J.5
Papp, Z.6
-
3
-
-
77955875027
-
The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization
-
20563532
-
The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. B Janic AS Arbab, ScientificWorldJournal 2010 10 1088 1099 20563532
-
(2010)
ScientificWorldJournal
, vol.10
, pp. 1088-1099
-
-
Janic, B.1
Arbab, A.S.2
-
4
-
-
0028114985
-
The implications of angiogenesis for the biology and therapy of cancer metastasis
-
10.1016/0092-8674(94)90187-2. 7525076
-
The implications of angiogenesis for the biology and therapy of cancer metastasis. IJ Fidler LM Ellis, Cell 1994 79 185 188 10.1016/0092-8674(94)90187- 2 7525076
-
(1994)
Cell
, vol.79
, pp. 185-188
-
-
Fidler, I.J.1
Ellis, L.M.2
-
5
-
-
84975525035
-
Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
-
10.1056/NEJM199512283332608. 7491141
-
Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. J Folkman, N Engl J Med 1995 333 1757 1763 10.1056/NEJM199512283332608 7491141
-
(1995)
N Engl J Med
, vol.333
, pp. 1757-1763
-
-
Folkman, J.1
-
6
-
-
28944440951
-
Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets
-
10.1111/j.1525-1438.2005.00132.x. 16174217
-
Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. KK Rasila RA Burger H Smith FC Lee C Verschraegen, Int J Gynecol Cancer 2005 15 710 726 10.1111/j.1525-1438.2005.00132.x 16174217
-
(2005)
Int J Gynecol Cancer
, vol.15
, pp. 710-726
-
-
Rasila, K.K.1
Burger, R.A.2
Smith, H.3
Lee, F.C.4
Verschraegen, C.5
-
8
-
-
0033840389
-
Vasculogenic mimicry and tumor angiogenesis
-
10666364
-
Vasculogenic mimicry and tumor angiogenesis. R Folberg MJ Hendrix AJ Maniotis, Am J Pathol 2000 156 361 381 10666364
-
(2000)
Am J Pathol
, vol.156
, pp. 361-381
-
-
Folberg, R.1
Hendrix, M.J.2
Maniotis, A.J.3
-
9
-
-
67651024222
-
Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer
-
19509557
-
Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. HS Tang YJ Feng LQ Yao, Int J Gynecol Cancer 2009 19 605 610 19509557
-
(2009)
Int J Gynecol Cancer
, vol.19
, pp. 605-610
-
-
Tang, H.S.1
Feng, Y.J.2
Yao, L.Q.3
-
10
-
-
34547121206
-
Hypoxia in cancer: Significance and impact on clinical outcome
-
10.1007/s10555-007-9055-1. 17440684
-
Hypoxia in cancer: significance and impact on clinical outcome. P Vaupel A Mayer, Cancer Metastasis Rev 2007 26 225 239 10.1007/s10555-007-9055-1 17440684
-
(2007)
Cancer Metastasis Rev
, vol.26
, pp. 225-239
-
-
Vaupel, P.1
Mayer, A.2
-
11
-
-
34447346001
-
Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia
-
17390008
-
Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia. LQ Yao YJ Feng JX Ding HM Jing CJ Xu SF Chen M Su LH Yin, Int J Oncol 2007 30 1069 1075 17390008
-
(2007)
Int J Oncol
, vol.30
, pp. 1069-1075
-
-
Yao, L.Q.1
Feng, Y.J.2
Ding, J.X.3
Jing, H.M.4
Xu, C.J.5
Chen, S.F.6
Su, M.7
Yin, L.H.8
-
12
-
-
43449091553
-
Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo
-
10.1111/j.1525-1438.2007.01034.x. 17645504
-
Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. M Su YJ Feng LQ Yao MJ Cheng CJ Xu Y Huang YQ Zhao H Jiang, Int J Gynecol Cancer 2008 18 476 486 10.1111/j.1525-1438.2007.01034.x 17645504
-
(2008)
Int J Gynecol Cancer
, vol.18
, pp. 476-486
-
-
Su, M.1
Feng, Y.J.2
Yao, L.Q.3
Cheng, M.J.4
Xu, C.J.5
Huang, Y.6
Zhao, Y.Q.7
Jiang, H.8
-
14
-
-
0031943661
-
LDL induces transcription factor activator protein-1 in human endothelial cells
-
9514417
-
LDL induces transcription factor activator protein-1 in human endothelial cells. Y Zhu JH Lin HL Liao O Friedli Jr L Verna NW Marten DS Straus MB Stemerman, Arterioscler Thromb Vasc Biol 1998 18 473 480 9514417
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 473-480
-
-
Zhu, Y.1
Lin, J.H.2
Liao, H.L.3
Friedli Jr., O.4
Verna, L.5
Marten, N.W.6
Straus, D.S.7
Stemerman, M.B.8
-
15
-
-
0035071510
-
Molecular determinants of ovarian cancer plasticity
-
11290546
-
Molecular determinants of ovarian cancer plasticity. AK Sood EA Seftor MS Fletcher LM Gardner PM Heidger RE Buller RE Seftor MJ Hendrix, Am J Pathol 2001 158 1279 1288 11290546
-
(2001)
Am J Pathol
, vol.158
, pp. 1279-1288
-
-
Sood, A.K.1
Seftor, E.A.2
Fletcher, M.S.3
Gardner, L.M.4
Heidger, P.M.5
Buller, R.E.6
Seftor, R.E.7
Hendrix, M.J.8
-
16
-
-
0037093107
-
Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor
-
12019179
-
Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. G Hopfl RH Wenger U Ziegler T Stallmach O Gardelle R Achermann M Wergin B Kaser-Hotz HM Saunders KJ WIlliams IJ Stratfrod M Gassmann I Desbaillets, Cancer Res 2002 62 2962 2970 12019179
-
(2002)
Cancer Res
, vol.62
, pp. 2962-2970
-
-
Hopfl, G.1
Wenger, R.H.2
Ziegler, U.3
Stallmach, T.4
Gardelle, O.5
Achermann, R.6
Wergin, M.7
Kaser-Hotz, B.8
Saunders, H.M.9
Williams, K.J.10
Stratfrod, I.J.11
Gassmann, M.12
Desbaillets, I.13
-
17
-
-
34548435229
-
RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion
-
10.1007/s10585-007-9081-y. 17587186
-
RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. X Zhi S Chen P Zhou Z Shao L Wang Z Ou L Yin, Clin Exp Metastasis 2007 24 439 448 10.1007/s10585-007-9081-y 17587186
-
(2007)
Clin Exp Metastasis
, vol.24
, pp. 439-448
-
-
Zhi, X.1
Chen, S.2
Zhou, P.3
Shao, Z.4
Wang, L.5
Ou, Z.6
Yin, L.7
-
18
-
-
77957110143
-
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
-
20797448
-
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect. AM Weljie FR Jirik, Int J Biochem Cell Biol 2010 20797448
-
(2010)
Int J Biochem Cell Biol
-
-
Weljie, A.M.1
Jirik, F.R.2
-
19
-
-
0032887340
-
Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
-
10487832
-
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. AJ Maniotis R Folberg A Hess EA Seftor LM Gardner J Pe'er JM Trent PS Meltzer MJ Hendrix, Am J Pathol 1999 155 739 752 10487832
-
(1999)
Am J Pathol
, vol.155
, pp. 739-752
-
-
Maniotis, A.J.1
Folberg, R.2
Hess, A.3
Seftor, E.A.4
Gardner, L.M.5
Pe'Er, J.6
Trent, J.M.7
Meltzer, P.S.8
Hendrix, M.J.9
-
20
-
-
2342428036
-
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity
-
10.1016/j.ajog.2004.02.011. 15118611
-
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. AK Sood MS Fletcher JE Coffin M Yang EA Seftor LM Gruman DM Gershenson MJ Hendrix, Am J Obstet Gynecol 2004 190 899 909 10.1016/j.ajog.2004. 02.011 15118611
-
(2004)
Am J Obstet Gynecol
, vol.190
, pp. 899-909
-
-
Sood, A.K.1
Fletcher, M.S.2
Coffin, J.E.3
Yang, M.4
Seftor, E.A.5
Gruman, L.M.6
Gershenson, D.M.7
Hendrix, M.J.8
-
21
-
-
77955402694
-
Telomerase in the ovary
-
10.1530/REP-10-0008. 20562297
-
Telomerase in the ovary. JP Liu H Li, Reproduction 2010 140 215 222 10.1530/REP-10-0008 20562297
-
(2010)
Reproduction
, vol.140
, pp. 215-222
-
-
Liu, J.P.1
Li, H.2
-
22
-
-
67649800380
-
The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: A prospective clinical study
-
19697627
-
The role of telomerase activity in predicting early recurrence of epithelial ovarian cancer after first-line chemotherapy: a prospective clinical study. B Ozmen CI Duvan G Gumus M Sonmezer M Gungor F Ortac, Eur J Gynaecol Oncol 2009 30 303 308 19697627
-
(2009)
Eur J Gynaecol Oncol
, vol.30
, pp. 303-308
-
-
Ozmen, B.1
Duvan, C.I.2
Gumus, G.3
Sonmezer, M.4
Gungor, M.5
Ortac, F.6
-
24
-
-
68849101834
-
A novel hTERT promoter-driven E1A therapeutic for ovarian cancer
-
10.1158/1535-7163.MCT-09-0056. 19671744
-
A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. X Xie JL Hsu MG Choi W Xia H Yamaguchi CT Chen BQ Trinh Z Lu JK Wokf RC Bast Jr MC Hung, Mol Cancer Ther 2009 8 2375 2382 10.1158/1535-7163.MCT-09-0056 19671744
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 2375-2382
-
-
Xie, X.1
Hsu, J.L.2
Choi, M.G.3
Xia, W.4
Yamaguchi, H.5
Chen, C.T.6
Trinh, B.Q.7
Lu, Z.8
Wokf, J.K.9
Bast Jr., R.C.10
Hung, M.C.11
-
25
-
-
74049117090
-
Oestrogen, telomerase, ovarian ageing and cancer
-
10.1111/j.1440-1681.2009.05238.x. 19566833
-
Oestrogen, telomerase, ovarian ageing and cancer. H Li ER Simpson JP Liu, Clin Exp Pharmacol Physiol 2010 37 78 82 10.1111/j.1440-1681.2009.05238.x 19566833
-
(2010)
Clin Exp Pharmacol Physiol
, vol.37
, pp. 78-82
-
-
Li, H.1
Simpson, E.R.2
Liu, J.P.3
-
26
-
-
77955289816
-
Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells
-
10.1371/journal.pone.0011241. 20574527
-
Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. F Spinella L Rosano DM Del C Di MR Nicotra PG Natali A Bagnato, PLoS One 2010 5 11241 10.1371/journal.pone. 0011241 20574527
-
(2010)
PLoS One
, vol.5
, pp. 511241
-
-
Spinella, F.1
Rosano, L.2
Del, D.M.3
Di, C.4
Nicotra, M.R.5
Natali, P.G.6
Bagnato, A.7
-
27
-
-
77953714481
-
Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts
-
10.1007/s00428-010-0929-1. 20473769
-
Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts. G Goteri G Lucarini A Zizzi C Rubini PR Di AL Tranquilli A Ciavattini, Virchows Arch 2010 456 703 710 10.1007/s00428-010-0929-1 20473769
-
(2010)
Virchows Arch
, vol.456
, pp. 703-710
-
-
Goteri, G.1
Lucarini, G.2
Zizzi, A.3
Rubini, C.4
Di, P.R.5
Tranquilli, A.L.6
Ciavattini, A.7
-
28
-
-
77956198446
-
Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk
-
20572162
-
Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. G Knechtel J Szkandera M Stotz G Hofmann U Langsenlehner P Krippl H Samonigg W Renner C Langner D Dehchamani A Gerger, Mol Carcinog 2010 49 805 809 20572162
-
(2010)
Mol Carcinog
, vol.49
, pp. 805-809
-
-
Knechtel, G.1
Szkandera, J.2
Stotz, M.3
Hofmann, G.4
Langsenlehner, U.5
Krippl, P.6
Samonigg, H.7
Renner, W.8
Langner, C.9
Dehchamani, D.10
Gerger, A.11
-
29
-
-
77950222705
-
Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway
-
10.1111/j.1447-0756.2009.01127.x. 20492406
-
Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. M Miyazawa M Yasuda M Fujita K Hirabayashi T Hirasawa H Kajiwara T Muranmatsu S Miyazaki M Harasawa N Matsui N Ogane M Murakami M Mikami T Yanase RY Osamura, J Obstet Gynaecol Res 2010 36 448 453 10.1111/j.1447-0756.2009.01127.x 20492406
-
(2010)
J Obstet Gynaecol Res
, vol.36
, pp. 448-453
-
-
Miyazawa, M.1
Yasuda, M.2
Fujita, M.3
Hirabayashi, K.4
Hirasawa, T.5
Kajiwara, H.6
Muranmatsu, T.7
Miyazaki, S.8
Harasawa, M.9
Matsui, N.10
Ogane, N.11
Murakami, M.12
Mikami, M.13
Yanase, T.14
Osamura, R.Y.15
-
30
-
-
77953356219
-
VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway
-
10.1159/000289569. 20389030
-
VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway. K Villaume M Blanc G Gouysse T Walter C Couderc M Nejjari C Vercherat M Cordire-Bussat C Roche JY Scoazec, Neuroendocrinology 2010 91 268 278 10.1159/000289569 20389030
-
(2010)
Neuroendocrinology
, vol.91
, pp. 268-278
-
-
Villaume, K.1
Blanc, M.2
Gouysse, G.3
Walter, T.4
Couderc, C.5
Nejjari, M.6
Vercherat, C.7
Cordire-Bussat, M.8
Roche, C.9
Scoazec, J.Y.10
-
31
-
-
77955179588
-
Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells
-
10.1371/journal.pone.0010966. 20532039
-
Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. M Zeng H Kikuchi MS Pino DC Chung, PLoS One 2010 5 10966 10.1371/journal.pone.0010966 20532039
-
(2010)
PLoS One
, vol.5
, pp. 510966
-
-
Zeng, M.1
Kikuchi, H.2
Pino, M.S.3
Chung, D.C.4
|